Many people with diabetes have struggled to afford insulin and oral medications, and the COVID-19 pandemic has made this issue even more pressing due to job losses and loss of insurance. Fortunately, patient assistance programs (PAPs) from pharmaceutical companies can help. For example, Novo Nordisk offers free insulin for 90 days to those who lost their insurance due to COVID-19. Similarly, Dexcom provides reduced-cost continuous glucose monitor (CGM) supplies. Other companies like Lilly and Sanofi also have PAPs that offer free or low-cost insulin and diabetes medications. To apply, you typically need to provide proof of income and insurance status. Healthcare providers can assist with the application process. Additionally, resources like the Association of Diabetes Care and Education Specialists and the American Diabetes Association offer tools and information to help you find affordable treatment options. Remember, it's important to discuss financial barriers with your healthcare team to find the best solutions.